Cencora, Inc. (COR): M&A transaction — Cencora completes $4.4B acquisition of Retina Consultants of America; raises FY2025 adjusted EPS guidance

Cencora, Inc.

Cencora acquires ~85% interest in Retina Consultants of America for $4.4B cash outlay, with post-closing adjustment.
RCA becomes Cencora subsidiary; certain RCA physicians and management retain minority equity interest.
FY2025 adjusted diluted EPS guidance raised to $15.15-$15.45 from prior $14.80-$15.10, reflecting RCA contribution and momentum.
Acquisition expands Cencora's specialty leadership, MSO solutions, and value for physicians and patients.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Cencora, Inc. completed an acquisition involving Webster Equity Partners (seller) / Retina Midco, Inc. ("Retina Consultants of America" or "RCA") for $4.4 billion (closed 2025-01-02).

Action: acquisition
Counterparty: Webster Equity Partners (seller) / Retina Midco, Inc. ("Retina Consultants of America" or "RCA")
Consideration: $4.4 billion
Closing: 2025-01-02

Exact text from the filing

in RCA of approximately 85%, with certain RCA physicians and members of the management team retaining a minority equity interest in RCA. The Company’s cash outlay at closing was $4.4 billion, which amount is subject to a customary post-closing purchase price adjustment. --- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 tm2432308d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Press

View on SEC.gov

32 m&a transactions filed in the last 30 days. Browse all m&a transactions →

Cencora, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-000366

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.